FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 29 strategically located sites across 7 countries, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments. To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com LinkedIn Privacy Policy: https://www.futuremeds.com/linkedin-privacy-policy
| Website | https://www.futuremeds.com |
| Revenue | $7.6 million |
| Employees | 373 (224 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+8 more
(view full list)
|
| Industry | Research Services |
| Keywords | Clinical Trials, Patient Centric, Quality Data, Data Delivery, Sponsor Services, Cro Services, Patient Recruitment, Clinical Research, Trial Management, Pharmaceutical Research, Healthcare Services, Healthcare Research, Medical Technology, Drug Development, Pharmaceutical Services, Medical Research |
| Competitors | Amazon, MinuteClinic, Walgreens, RITE AID, Scripps Health, Genoa Healthcare, Capsule, PillPack, Medly, SimpleHealth +40 more (view full list) |
Looking for a particular FutureMeds employee's phone or email?
The FutureMeds annual revenue was $7.6 million in 2026.
Radoslaw Janiak is the CEO of FutureMeds.
224 people are employed at FutureMeds.